Detalles de la búsqueda
1.
Associations of postprandial ghrelin, liver-expressed antimicrobial peptide 2 and leptin levels with body composition, disease progression and survival in patients with amyotrophic lateral sclerosis.
Eur J Neurol
; 31(1): e16052, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37658515
2.
Lower hypothalamic volume with lower body mass index is associated with shorter survival in patients with amyotrophic lateral sclerosis.
Eur J Neurol
; 30(1): 57-68, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36214080
3.
Venous creatinine as a biomarker for loss of fat-free mass and disease progression in patients with amyotrophic lateral sclerosis.
Eur J Neurol
; 28(11): 3615-3625, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34216521
4.
Variation in Resting Metabolic Rate Affects Identification of Metabolic Change in Geographically Distinct Cohorts of Patients With ALS.
Neurology
; 102(5): e208117, 2024 Mar 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38350046
5.
Use of hip- versus wrist-based actigraphy for assessing functional decline and disease progression in patients with motor neuron disease.
J Neurol
; 270(5): 2597-2605, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36740646
6.
Low plasma hyaluronan is associated with faster functional decline in patients with amyotrophic lateral sclerosis.
Amyotroph Lateral Scler Frontotemporal Degener
; 23(1-2): 42-48, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34569358
Resultados
1 -
6
de 6
1
Próxima >
>>